Dr. Stephanie Rimka is a pioneering clinician who authored the book, "Receive: The Dance of Feminine Power."

Learn more at https://drrimka.com

EPISODE SUMMARY BELOW:

1. Vision for Treatment Islands

Ambition to build residential centers on multiple islands

Preference to remain near the United States and in jurisdictions allowing gun ownership

2. Challenges with International Patients and Systems

Difficulties treating patients from Australia and Canada

Systemic obstacles to providing care across borders

3. COVID-19 Era Reflections and Medical Discourse

Early preparedness with peptide therapies and supportive protocols -- At the pandemic's onset, certain clinicians organized protocols incorporating peptides (e.g., thymosin alpha-1), nicotine, methylene blue, and adjuncts like ivermectin and hydroxychloroquine to support immunity and nutrient delivery, leveraging prior peptide therapy experience.

Belief that the pandemic response was misleading and coercive

Censorship and platform restrictions -- Recounting bans and throttling on Instagram, TikTok, and Facebook, resorting to coded language (e.g., "cupcake") to avoid content moderation and experiencing extended live bans.

4. Social Media Enforcement and Pharmaceutical Influence

Allegation of coordinated reporting by Eli Lilly -- Dr. Rimka says Instagram notified her that Eli Lilly reported her account, coinciding with actions against peers. She speculates that microdosing education threatened sales by reducing dosing volume.

Selective enforcement and inconsistent standards -- Frustration is expressed over perceived preferential treatment of similar content by others and retroactive flagging of archived posts, reinforcing a sense of targeted suppression.

5. Regulatory Changes in Peptide Therapy

Historical context and global research base

Reclassification and access restrictions post-COVID -- Key peptides (e.g., TA1) became difficult to source after regulatory changes limiting compounding pharmacies. Clinicians turned to research-use-only and international sources, creating delays and uncertainty, which Rimka attributes to pharmaceutical efforts to limit widespread peptide use.

Shift toward FDA approvals and evolving legal landscape

6. Regulatory Reclassification, Patents, and Natural Substances

Peptides are naturally occurring and should not be restricted

Pharma patents delivery systems/binders to capture markets

7. Pharma Influence and COVID-19 Coordination Claims

Early warnings from contacts in China -- Dr. Rimka cites late-2019 warnings from contacts in Hong Kong/Shanghai who moved to Singapore and ceased WeChat communications, interpreted as signals of impending danger.

Pharma's dominant role over government -- Assertions that pharma influences U.S. policy and suspect foul play in COVID-19's origins, drawing parallels to alleged bioweapon narratives involving Lyme disease and alpha-gal syndrome.

8. Intent Behind Global Response to COVID-19

Population control and compliance -- Mass vaccination and public health measures were designed to control and desensitize populations, testing compliance via mandates and social cues.

Desensitization to tracking and bio-integrated technologies -- Warn of normalization of biometrics, implanted chips, and digital credentials, eroding autonomy and reshaping identity.

9. Vaccination Schedules, Immune Claims, and Endocrine Concerns

Modern immunization schedules are excessive -- The interlocutors argue current infant vaccine schedules are unprecedentedly large compared to past generations.

Rejection of autoimmune disease concept

Vaccines and environmental endocrine disruptors -- Vaccine components and environmental chemicals (BPA, phthalates, microplastics) may influence sexuality and identity, citing animal studies and extrapolating to human exposures.

10. Nanotechnology, Frequencies, and Neurofeedback

Potential for nano-chips/robots to alter physiology -- Dr. Rimka references public claims of nanotechnology capable of modulating cellular function and suggests undisclosed uses may exist, potentially via injections or environmental exposure.

Brain manipulation and external frequency influences -- As a neurofeedback practitioner, Dr. Rimka describes modulating brain states via EEG-guided training and hypothesize that external infrastructures (e.g., 5G towers) could emit localized pulses affecting sleep, fatigue, and headaches.

11. Autism, Vaccine Injury, and Institutional Trust

Correlation between vaccines and neurotoxicity -- The conversation frames vaccination as a high risk, referencing vaccine injury claims and the existence of a Vaccine Court, attributing neurotoxic effects to schedule components.

CDC and FDA as misinformation sources

12. Personal Safety, Loss, and Public Pressure

Denial of suicidality and acknowledgment of pressure -- Dr. Rimka confirms she is not suicidal, reflecting on past fears during heightened public controversy and the burden of advocacy when her child was young.

Partner's death and suspected vaccine link

Practitioner deaths and mentor loss -- A period of suspicious deaths among functional health practitioners, including her mentor, Dr. John Hicks, amplifying her sense of risk in the field.

13. Vaccine Lot Variability and Experimental Control Claims

Variable vaccine lots and possible placebos -- Some vaccine lots may have been placebos, implying controlled experimentation and differential risk among recipients.

14. Peptides and Early Pandemic Protocols

TA1, nicotine, methylene blue, ivermectin, and hydroxychloroquine -- Dr. Rimka details clinician-driven "stacking" strategies combining TA1 with nicotine and methylene blue, alongside ivermectin and hydroxychloroquine, to enhance immune support, nutrient delivery, and reduce dosages during shortages. Public awareness of peptides was limited at the time.

15. Lyme Disease, Alpha-gal, and Non-Vaccine Strategies

Lyme and alpha-gal as engineered threats -- Dr. Rimka characterizes Lyme disease as man-made with multiple vectors and views alpha-gal syndrome as unprecedented and possibly engineered, linking observed field anomalies to concerning patterns and anticipated vaccine rollouts.

System optimization and aggressive post-bite protocols -- Recommended approaches include immune modulation, readiness with specific products, and rapid "killing and binding" after bites. CellCore Biosciences protocols spanning 10–12 months for chelation and pathogen elimination are endorsed, with guidance to work with trained clinicians.

Electromagnetic devices and mitochondrial charge -- Bob Beck protocol devices (e.g., SOTA) and frequency-based tools to raise cellular/mitochondrial charge, positing cellular voltage as a fundamental determinant of recovery capacity.

Practical toolkit -- Suggested on-hand items include DMSO, turpentine, ivermectin, silver, specific devices, peptides like TA1, and tinctures for Borrelia and Babesia, with an emphasis on early, aggressive intervention.

16. Public Communication, Professional Constraints, and Promotion

Polarizing messaging and informed consent

Tension between education and platform policy

Credentials, partnerships, and book -- Dr. Rimka discusses her book, "Receive: The Dance of Feminine Power," emphasizing balanced masculine-feminine energies, honoring reception to reduce burnout, and reflections on motherhood and work. She also suggests a peptide stack (Klotho, Follistatin, Cell Factor).

510. Dr. Stephanie Rimka :: What Big Pharma Doesn't Want You to Know